Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327101 · ClinicalTrials.gov registry record
Patient Preferences for Leadless Pacemakers
A clinical trial of Bradycardia and Cardiac Pacemaker, Artificial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 117
- Enrollment target
- 11
- Study locations
NCT05327101: Completed study of Bradycardia and Cardiac Pacemaker, Artificial, sponsored by Abbott Medical Devices.
NCT05327101 is a study of Bradycardia and Cardiac Pacemaker, Artificial that has completed, run by Abbott Medical Devices. The registered enrollment target is 117 participants, below the 4,409-participant average among 29 other Bradycardia trials with a reported enrollment target (97% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05327101, a study of Bradycardia and Cardiac Pacemaker, Artificial, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 11
- Study locations
Study Summary
Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers
Primary Outcome
Ranking of six pacemaker device features from most concerning (1) to least concerning (6)
Conditions Studied
Interventions
- OTHER Patient Preference Survey
Study Locations (11)
Arkansas
- Arrhythmia Research Group - Jonesboro
- Arkansas Heart Hospital - Little Rock
Illinois
- Rush University Medical Center - Chicago
- Prairie Education & Research Cooperative - Springfield
Arizona
- Honor Health - Scottsdale
California
- Pacific Heart Institute - Santa Monica
Florida
- Baptist Medical Center - Jacksonville
Massachusetts
- Charlton Memorial Hospital - Fall River
New York
- New York Presbyterian Hospital/Cornell University - New York
Oklahoma
- Hightower Clinical - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-06-13 |
What the finished NCT05327101 record still lists
NCT05327101 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 4,409-participant average among 29 other Bradycardia trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Patient Preference Survey is the first listed.
NCT05327101 lists 11 locations in 9 states (Arkansas, Illinois, Arizona).
Frequently Asked Questions
What is clinical trial NCT05327101 about?
NCT05327101 is a clinical study titled "Patient Preferences for Leadless Pacemakers". Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers
What is the current status of trial NCT05327101?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2022-03-28. Estimated completion is 2023-06-13.
What conditions does trial NCT05327101 study?
This clinical trial studies the following conditions: Bradycardia, Cardiac Pacemaker, Artificial, Cardiac Rhythm Disorder.
What interventions are being tested in trial NCT05327101?
The interventions under investigation include: Patient Preference Survey (OTHER).
Who is sponsoring clinical trial NCT05327101?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05327101 being conducted?
This trial has 11 study locations across Arizona, Arkansas, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05327101's enrollment target sits among peer trials
117 24th of 29 higher than 6 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI